Evidence map›Paper›PMID 33489706›Full record

ArticleInternational cancer conference journal2021

Bulky peritoneal carcinosarcoma with tiny high-grade serous carcinoma of the fallopian tube: a case report.

Ayaka Nakashima, Yasuyo Maruyama, Haruya Saji, Tomoo Hirabuki, Hiroyuki Mitomi

Open access · greenAbstract read
In one paragraph

Article in International cancer conference journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ayaka NakashimaDepartment of Obstetrics and Gynecology, Odawara Municipal Hospital, 46 Kuno, Odawara, Kanagawa 250-8558 Japan.ORCID 0000-0003-2929-798X
Yasuyo MaruyamaDepartment of Obstetrics and Gynecology, Odawara Municipal Hospital, 46 Kuno, Odawara, Kanagawa 250-8558 Japan.
Haruya SajiDepartment of Obstetrics and Gynecology, Fujisawa Municipal Hospital, 2-6-1 Fujisawa, Fujisawa, Kanagawa 251-8550 Japan.
Tomoo HirabukiDepartment of Obstetrics and Gynecology, Odawara Municipal Hospital, 46 Kuno, Odawara, Kanagawa 250-8558 Japan.
Hiroyuki MitomiDepartment of Diagnostic Pathology, Odawara Municipal Hospital, 46 Kuno, Odawara, Kanagawa 250-8558 Japan.
Odawara Municipal Hospital · JPFujisawa City Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peritoneal carcinosarcoma is a highly aggressive and uncommon neoplasm that has carcinomatous and sarcomatous components; the malignancy rarely localizes to the omentum. We report a case of a bulky peritoneal carcinosarcoma with tiny high-grade serous carcinoma of the fallopian tube. A 60-year-old female with a huge pelvic mass (12 cm in diameter) underwent a total abdominal hysterectomy, bilateral salpingo-oophorectomy, and omentectomy for tumor debulking. Pathological findings showed minimally invasive high-grade serous carcinoma of the left fallopian tube and carcinosarcoma of the omentum. Similar p53 diffuse immunostaining in the omental carcinosarcoma and the tubal carcinoma provides evidence for a clonal relationship between the two neoplasias. This case suggests a small serous carcinoma, originating in the tubal mucosa, subsequently became implanted in the omentum and grew preferentially, converting to a carcinosarcoma at a remote site.

Indexed as

Case reportConversion theoryFallopian tubeHigh-grade serous carcinomap53Peritoneal carcinosarcomaSerous tubal intraepithelial carcinoma

Identifiers

PMID33489706
PMCPMC7797399
OpenAlexW3092914326

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.